Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.
Read More
Bruyère Health is creating a Master Retail Strategy that will help revamp retail and food services acros...
Four knowledge brokers share how collaboration is at the heart of evidence-based care
Earlier this year, we launched a pilot project at our Market Site using Friendlier, a reusable food container...
September 17 marks Rehabilitation Day, a celebration of the critical role of rehabilitation in recovery and q...
An international team of researchers has received $1 million to launch one of the largest multinational studi...
New research published in Palliative Care and Social Practice shows that food is much more than fuel for pall...
The newly released Equity Extension to the STROBE Guideline published in The BMJ and JAMA Network Open covers...
Bruyère Health Research Institute has been redesignated as a PAHO/WHO Collaborating Centre and selected ...
We have entered a formal collaboration with Telfer Executive Programs at the University of Ottawa to deliver ...